Task: Answer the multiple-choice question.
Query: Which drug exhibits a -37.039% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any additional words.
Options:
a. COCCCn1cnc2c(c1=O)c1nc3ccccc3nc1n2-c1ccc(C)cc1
b. COc1ccc(/C(C)=N/NC(=O)CNC(=O)c2ccco2)c(OC)c1
Answer: a. COCCCn1cnc2c(c1=O)c1nc3ccccc3nc1n2-c1ccc(C)cc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
COCCCn1cnc2c(c1=O)c1nc3ccccc3nc1n2-c1ccc(C)cc1
COCCCn1cnc2c(c1=O)c1nc3ccccc3nc1n2-c1ccc(C)cc1
13-(3-methoxypropyl)-17-(4-methylphenyl)-2,9,13,15,17-pentazatetracyclo[8.7.0.03,8.011,16]heptadeca-1,3,5,7,9,11(16),14-heptaen-12-one